139 related articles for article (PubMed ID: 10398401)
1. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
Liu Z; Song D; Kramer A; Martin AC; Dandekar T; Schneider-Mergener J; Bautz EK; Dübel S
J Mol Recognit; 1999; 12(2):103-11. PubMed ID: 10398401
[TBL] [Abstract][Full Text] [Related]
2. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
3. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.
Vajdos FF; Adams CW; Breece TN; Presta LG; de Vos AM; Sidhu SS
J Mol Biol; 2002 Jul; 320(2):415-28. PubMed ID: 12079396
[TBL] [Abstract][Full Text] [Related]
5. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
6. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
[TBL] [Abstract][Full Text] [Related]
7. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
Sompuram SR; Den W; Sharon J
J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
[TBL] [Abstract][Full Text] [Related]
9. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
[TBL] [Abstract][Full Text] [Related]
11. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
[TBL] [Abstract][Full Text] [Related]
12. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
[TBL] [Abstract][Full Text] [Related]
13. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
14. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
15. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED
J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998
[TBL] [Abstract][Full Text] [Related]
17. Identification of a nucleic acid-binding region within the largest subunit of Drosophila melanogaster RNA polymerase II.
Kontermann RE; Kobor M; Bautz EK
Protein Sci; 1993 Feb; 2(2):223-30. PubMed ID: 8443600
[TBL] [Abstract][Full Text] [Related]
18. Probing the interaction between a high-affinity single-chain Fv and a pyrimidine (6-4) pyrimidone photodimer by site-directed mutagenesis.
Kobayashi H; Morioka H; Tobisawa K; Torizawa T; Kato K; Shimada I; Nikaido O; Stewart JD; Ohtsuka E
Biochemistry; 1999 Jan; 38(2):532-9. PubMed ID: 9888792
[TBL] [Abstract][Full Text] [Related]
19. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
Brown M; Rittenburg MB; Chen C; Roberts VA
J Immunol; 1996 May; 156(9):3285-91. PubMed ID: 8617951
[TBL] [Abstract][Full Text] [Related]
20. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]